Kevin Sheth

Dr. Sheth joined Astrocyte Pharmaceutical’s Scientific Advisory Board in February of 2019. He is the founding Chief of the Division of Neurocritical Care & Emergency Neurology at the Yale School of Medicine. Dr. Sheth focuses on the advancement of therapies for acute brain injury such as stroke and brain hemorrhage and is recognized for his leadership in the prevention, acute treatment, and recovery. In pioneering the development of new strategies to treat brain swelling, his work has changed the fundamental approach to brain injury in the ICU, and his team at Yale has served as a national model for academic critical care neurology units.

Dr. Sheth is currently the principal investigator for two NIH neuroscience networks, NeuroNEXT and StrokeNet. He has served as Principal Investigator (PI) or co-PI for 8 multicenter clinical trials in stroke, as well as chair for clinical endpoint and data safety monitoring committees for several pivotal studies. He is a winner of the prestigious Robert Siekert Award from the American Heart Association (AHA), the Derek Denny Brown Award from the American Neurological Association, and an elected member of the American Society for Clinical Investigation (ASCI). Dr. Sheth is the author of over 250 publications and is an Associate Editor at Neurology and on the editorial boards for Stroke and Neurosurgery.